GENE

GENE Company Financials

$1.05
*  
0.023
2.14%
Get GENE Alerts
*Delayed - data as of Jul. 10, 2014  -  Find a broker to begin trading GENE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time


Annual Income Statement (values in 000's) Get Quarterly Data

Period Ending: Trend 6/30/2013 6/30/2012 6/30/2011 6/30/2010
Total Revenue
$3,091 $3,784 $4,919 $4,916
Cost of Revenue
$1,781 $1,997 $2,179 $2,723
Gross Profit
$1,311 $1,786 $2,741 $2,193
Operating Expenses
Research and Development
$3,169 $4,130 $4,690 $6,259
Sales, General and Admin.
$6,479 $8,327 ($3,285) $5,735
Non-Recurring Items
$0 $0 $0 $0
Other Operating Items
$0 $0 $0 $0
Operating Income
($8,338) ($10,671) $1,336 ($9,801)
Add'l income/expense items
$216 $5,423 ($306) $0
Earnings Before Interest and Tax
($8,522) ($5,383) $1,053 ($9,355)
Interest Expense
$36 $46 $88 $0
Earnings Before Tax
($8,558) ($5,430) $965 ($9,355)
Income Tax
$0 $0 $0 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
($400) ($135) $0 $0
Net Income-Cont. Operations
($8,958) ($5,565) $965 ($9,355)
Net Income
($8,558) ($5,430) $965 ($9,355)
Net Income Applicable to Common Shareholders
($8,558) ($5,430) $965 ($9,355)

See also: Company Financials data entry page